Michael Carson - 18 Mar 2022 Form 3 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Vice President, Finance
Signature
/s/ Michael Carson
Issuer symbol
NVCT
Transactions as of
18 Mar 2022
Net transactions value
$0
Form type
3
Filing time
24 Mar 2022, 08:10:42 UTC
Next filing
08 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NVCT Common Stock 27,300 18 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units (RSUs) granted on November 1, 2021. These RSUs vest over a 3-year period, with 1/3 vesting on each of the first three anniversaries of the grant date.